⬤ Loading…
$6.8B
Market Cap
10.0
P/E
1.27
PEG
4.5%
ROCE
22.4%
ROE
0.54
D/E
15.0%
OPM
-17.0%
% from 52W High
69
α RS
🔍 G is showing a multi-screen setup because it matches 4 of 39 tracked screener presets, Sector RRG has Technology in the Improving quadrant with the trail still strengthening, and RS Rating is 69. The main caution: the Graham Defensive preset's Backtest win rate is only 47.4%. Net: Mixed signal stack, not a recommendation. ? Conviction RRG RS Rating Backtest
Sources
Conviction 4/39 · Technology in Improving quadrant · RS Rating 69 · Backtest win rate 47.4%
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for G including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
— Excellent
— Good
— Average
— Poor
By Category
📊 Peer Medians
About

Genpact Limited, an agentic and advanced technology solutions company, provides digital transformation, business process management, technology, data, analytics, and artificial intelligence (AI) services to enterprises in India, the rest of Asia, North and Latin America, and Europe. Its Financial Services segment offers customer onboarding, customer service, collections, retail and commercial loan operations, payment operations, mortgage origination and servicing, compliance, wealth management, capital market operations support, financial crime and risk management, proprietary insurance policy suite, underwriting support, new business processing, policy administration, customer, claims management, catastrophe and exposure/risk modeling, actuarial services, end-to-end third-party administration for property and casualty claims, and technology services. The company's Consumer and Healthcare segment provides demand generation, sensing and planning, supply chain planning and management, pricing and trade promotion management, deduction recovery management, order management, digital commerce, customer experience, lifecycle management, regulatory operations, chemistry manufacturing control compliance, regulatory information management, claims processing and adjudication, claims recovery and payment integrity, revenue cycle management, health equity analytics, and care services. Its High Tech and Manufacturing segment offers solutions for trust and safety, advertising sales support, customer and user experience, customer care support, supply chain management, direct and indirect procurement, logistics, field, aftermarket support, and engineering services. It offers digital operations, data-tech-AI, advisory, agent technology; and finance and accounting, human resources, sales and commercial operations, marketing, and global business solutions. The company has strategic alliance with Google Cloud. The company was founded in 1997 and is based in Hamilton, Bermuda.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
⭐ Superinvestors Holding G
View All Superinvestors →
Manager Shares Value % of Fund Period
Jim Simons Renaissance Technologies LLC 441.8K $16.5M 0.03% Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
🎙 Management Tone Confident Specific → Stable 4 quarters Full tone analysis in Intelligence →
📊 MIXED Genpact Q1 2026 revenue $1.296B, up 6.7%; ATS grows 24%; agentic contract value nearly doubles vs FY25
Revenue & Profitability
Total revenue: $1.296 billion, up 6.7% YoY. Net income: $148 million. Adjusted operating income: $224 million (17.3% margin). Adjusted diluted EPS: $0.98, up 16.7% YoY. Operating cash flow used $24 million, ending cash balance $578 million. Share repurchases of $70 million and dividends of $32 million were returned to shareholders.
Outlook
Management sees strong and increasing demand across all cohorts and geographies, with pipeline, inflows, and backlog at record levels. They believe 2026 is a moment of convergence for market shifts and Genpact's positioning. No macro headwinds were discussed; the outlook is consistently positive with expectations for at least 7% total revenue growth and at least 20% ATS growth for the full year.
Growth Drivers
Key growth levers include Advanced Technology Solutions (especially agentic and data & AI), which nearly doubled its contract value in Q1 relative to all of 2025. Large deals remain strong with six signed in the quarter. Partner-related revenue grew 35% YoY and now accounts for nearly 13% of total revenue. New client wins include a European insurance leader and Bendigo Bank in Australia.
Balance Sheet & CapEx
Not discussed in this earnings call.
Margins
Gross margin expanded 110 basis points YoY to 36.4% in Q1. Full-year gross margin guidance is 36.5% (up 50bps), and adjusted operating income margin guidance is 17.7% (up 25bps). Operating leverage is improving as revenue growth decouples from headcount, especially in agentic and AI-led delivery.
Key Risks
Not discussed in this earnings call.
Generated by AI · Q1 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q2 2026 Q2 2026 2026-08-06
Q2 2026 saw 7.1% revenue growth and 24% ATS growth, with gross margin expanding for the 13th straight quarter. The company is accelerating its pivot to Agentic Operations, driving record bookings and recurring revenue, and expects at least 7% revenue growth and 25% ATS growth for 2026.
Q1 2026 Q1 2026 2026-05-07
Q1 2026 delivered record results with 6.7% revenue growth and 24% growth in Advanced Technology Solutions, now 27% of total revenue. Gross margin expanded, recurring revenue base strengthened, and six large deals were signed, supporting a robust outlook for the year.
Q4 2025 Q4 2025 2026-02-05
Delivered record revenue and margin expansion in 2025, driven by rapid growth in Advanced Technology Solutions and agentic offerings. 2026 guidance calls for at least 7% revenue growth, continued margin gains, and double-digit EPS growth, supported by robust demand and record backlog.
Q3 2025 Q3 2025 2025-11-06
Q3 2025 saw 7% revenue growth and 20% growth in advanced technology solutions, with gross margin and EPS exceeding expectations. Full-year guidance was raised, and strong demand for AI and agentic solutions is driving both new and existing client growth.
Q2 2025 Q2 2025 2025-08-07
Q2 revenue grew 7% year-over-year to $1.25B, with advanced technology solutions up 17% and adjusted EPS up 11%. Full-year guidance was raised for revenue, margin, and EPS, reflecting strong AI-driven growth and robust deal pipelines.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.